ArticleFrontiers in genetics2021

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer.

Daniel L Hertz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.